Proteins and Peptides
3 April 2025
BioMarin Announces Positive Pivotal Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with Phenylketonuria2 April 2025
ESTEVE signs a licensing agreement for a severe primary insulin-like growth factor 1 deficiency treatment1 April 2025
Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia17 March 2025
AstraZeneca enters license agreement with Alteogen for subcutaneous formulations of multiple oncology assets9 March 2025
Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis15 February 2025
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of DiabetesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports